Compare Charlie Hospital Semarang Tbk. (RSCH) vs Salim Ivomas Pratama Tbk. (SIMP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charlie Hospital Semarang Tbk. vs Salim Ivomas Pratama Tbk. — how do they compare? Charlie Hospital Semarang Tbk. trades at Rp270 (market cap 742B, 29.45M 24h volume), while Salim Ivomas Pratama Tbk. trades at Rp565 (market cap 8.68T, 9.06M 24h volume). The key difference: Salim Ivomas Pratama Tbk. is far larger — about 11.7× Charlie Hospital Semarang Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (29.45M versus 9.06M). Which is the better fit depends on your goals.
| RSCH | SIMP | |
|---|---|---|
Market Cap | 742B | 8.68T |
Volume | 29.45M | 9.06M |
Lot | 294.49K | 90.58K |
Turnover | 8.14B | 5.13B |
Average Price | 276.35 | 566.65 |
Value | 8.14B | 5.13B |
Indicative Equilibrium Price | 270 | 565 |
Indicative Equilibrium Volume | 103 | 2.9K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Charlie Hospital Semarang Tbk.
PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →About Salim Ivomas Pratama Tbk.
PT Salim Ivomas Pratama Tbk (the company) was established under its original name of PT Ivomas Pratama base on notarial deed No.65 of Mrs Maria Kidarsa, S.H, dated on 12 Aug, 1992. The Company’s articles of association has been amended several times, most recently by notarial deed No. 46 of Benny Kristianto, S.H., dated Dec 14, 2010, concerning among others, the change in the Company’s name, par value and public offering.
Read more on SIMP →
